MEEDER ASSET MANAGEMENT INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$7,000
-78.8%
170
-77.1%
0.00%
-100.0%
Q2 2022$33,000
+266.7%
741
+223.6%
0.00%
Q1 2022$9,000
+125.0%
229
+112.0%
0.00%
Q3 2021$4,000
-50.0%
108
-35.3%
0.00%
Q2 2021$8,000
+60.0%
167
+47.8%
0.00%
Q1 2021$5,000
+400.0%
113
+653.3%
0.00%
Q4 2020$1,000
-83.3%
15
-93.0%
0.00%
Q3 2020$6,0000.0%2140.0%0.00%
Q2 2020$6,000214
+919.0%
0.00%
Q4 2019$0
-100.0%
21
-97.9%
0.00%
-100.0%
Q4 2018$14,000
-78.8%
983
-72.8%
0.00%
-80.0%
Q3 2018$66,000
-99.9%
3,608
-28.1%
0.01%
-28.6%
Q2 2018$84,706,000
+445721.1%
5,021
+426.9%
0.01%
+250.0%
Q1 2018$19,000
+533.3%
953
+417.9%
0.00%
Q3 2017$3,000
-57.1%
184
-64.2%
0.00%
-100.0%
Q2 2017$7,000
-22.2%
514
-25.0%
0.00%0.0%
Q1 2017$9,000
-10.0%
685
-33.8%
0.00%0.0%
Q4 2016$10,000
-93.5%
1,035
-94.2%
0.00%
-93.3%
Q2 2016$155,00017,9550.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders